Medline reports revenue growth, lower operating income
Medline Inc. reported results for the third quarter of 2026: revenue rose to $7.86 billion. Meanwhile, the company’s operating income fell 12.9% compared to the same quarter last year and 26.3% for the first nine months of the year compared to the same period in 2025.
Key points
- Medline’s third-quarter revenue was $7,856 million, up 10.4% from a year earlier.
- Company management confirmed the effectiveness of its disclosure controls as of the end of the quarter.
- Former Chief Operating Officer Stephen L. Miller terminated his trading plan—a preset selling schedule—on August 13, 2026.
Financial results and debt transactions
Medline’s third-quarter revenue was $7,856 million, up 10.4% from a year earlier. Since the start of 2026, total revenue reached $22,893 million (+10.9% year-over-year). Despite revenue growth, operating income for the quarter fell to $500 million, and to $1,317 million for the nine months. The company generated significant cash flow: operating cash flow for the nine months rose 42% to $2,152 million. Additionally, on October 22, the company prepaid $750 million in principal on its 2033 credit facility.
Quarter vs the same quarter a year earlier
Governance, litigation, and corporate announcements
Company management confirmed the effectiveness of its disclosure controls as of the end of the quarter. No changes to internal control over financial reporting were identified. The company reported no defaults on its securities and stated it does not expect pending litigation to have a material negative impact on its financial condition.
Shareholders and insider transactions
Former Chief Operating Officer Stephen L. Miller terminated his trading plan—a preset selling schedule—on August 13, 2026. This plan covered up to 100% of Class A shares to be issued upon the vesting of 808,451 employee incentive units.
According to reports from November 6, investment firm GIC Private Limited owns 74,634,102 shares, or 8.49% of the class. The stakes of GIC Special Investments Private Limited and Hux Investment Pte. Ltd. are 59,408,506 shares each (6.76% of the class each).
What to watch
Shareholders should monitor subsequent quarterly reports to assess whether operating profit margins stabilize amid declines in 2026 compared to last year's figures.
Original sources
- 10-Q risk factors compared with the 10-Q filing, August 5, 2026
- financial data (XBRL)
- SCHEDULE 13G/A filing, November 6, 2026
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Medline
A notification in your browser or on your phone when we publish about Medline. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
